DIabetic Retinopathy Candesartan Trials

NCT00252694 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

4717

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: candesartan

Sponsor

AstraZeneca

Collaborators

[object Object]